Document:

EX-10.1

 Exhibit 10.1 

Viatris Inc. 2020 Stock Incentive Plan 

Section 1. Purpose. The purpose of the Viatris Inc. 2020 Stock Incentive Plan (the “Plan”) is to incentivize
employees, non-employee Directors and other service providers of the Company and its Affiliates by making available to them the benefits of equity-based and other incentive awards, as the Company believes that
these incentives assist in the recruitment and retention of employees, non-employee Directors and other service providers and stimulate the efforts of these service providers towards the success of the Company
and its Affiliates. 
 Section 2. Definitions. As used in the Plan, the following terms shall have the meanings set forth below:

 (a) “Affiliate” shall mean (i) any Person that directly, or through one or more intermediaries, controls, or is
controlled by, or is under common control with, the Company or (ii) any entity in which the Company has a significant equity interest, as determined by the Committee. Except as limited by Section 5 of the Plan, the employees, non-employee Directors and other Service Providers of such entity or Person described in (i) or (ii) above are eligible to participate in the Plan, as determined by the Committee. 

(b) “Award” shall mean any Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit, Performance
Award, Performance Share Award, Performance Cash Award, Total Shareholder Return Unit or Other Stock Unit Award, or Dividend Equivalents or Dividend Equivalent Units with respect to any of the foregoing, if applicable, or any other right, interest
or option relating to Shares issued and delivered pursuant to the provisions of the Plan. 
 (c) “Award Agreement” shall
mean any written or electronic agreement, contract or other instrument or document evidencing any Award granted by the Committee hereunder, which in the sole and absolute discretion of the Committee may, but need not, be signed or acknowledged by
the Company or the Participant. 
 (d) “Board” shall mean the Company’s Board of Directors. 

(e) “BCA” shall mean the Business Combination Agreement by and among Pfizer Inc., the Company, Mylan N.V. and the other
parties thereto, as amended. 
 (f) “Cause” shall mean, unless otherwise set forth in an applicable award agreement,
(i) a willful breach of duty in the course of service or employment or (ii) commission of an act that constitutes a felony (other than a traffic-related offense) under the laws of the United States or any state thereof or any similar
criminal act in a jurisdiction outside the United States. No act or failure to act shall be deemed “willful” unless done, or omitted to be done, not in good faith and without reasonable belief that the action or omission was in the best
interest of the Company and its Affiliates; provided, however, that to the extent a Participant is also eligible to receive benefits pursuant to any plan or individual agreement of or with the Company or an Affiliate that provides for
separation or severance benefits upon a termination without “cause,” the definition of “cause” in such other plan or agreement shall apply. 

 (g) “Change in Control” shall mean the consummation of any of the following
events:
 (i) at any time during the initial twelve-month period following the Effective Date and each successive
twelve-month period thereafter, at least a majority of the Board shall cease to consist of “Continuing Directors” (meaning directors of the Company who either were directors as of the Effective Date, or who subsequently became
directors and whose election, or nomination for election by the Company’s stockholders, was approved by a majority of the then Continuing Directors, provided that any director whose initial assumption of office is in connection with an
actual or threatened election contest, including but not limited to a consent solicitation, relating to the election of directors of the Company shall not qualify as a “Continuing Director”); 

(ii) any “person” or “group” (as determined for purposes of Section 13(d)(3) of the Exchange Act,
except any majority-owned subsidiary of the Company or any employee benefit plan of the Company or any trust thereunder), shall have acquired “beneficial ownership” (as determined for purposes of Securities and Exchange Commission
(“SEC”) Regulation 13d-3) of Shares having 30% or more of the voting power of all outstanding Shares, unless such acquisition is approved by a majority of the directors of the Company in
office immediately preceding such acquisition; 
 (iii) the consummation of (A) a merger, consolidation, statutory share
exchange or similar form of corporate transaction involving (x) the Company or (y) any of its Subsidiaries, but in the case of this clause (y) only if Company Voting Securities (as defined below) are issued or issuable (each of the
events referred to in this clause (A) being hereinafter referred to as a “Reorganization”) or (B) the sale or other disposition of all or substantially all the assets of the Company to an entity that is not an Affiliate (a
“Sale”), unless, immediately following such Reorganization or Sale, (1) all or substantially all the “beneficial owners” (as used in SEC Regulation 13d-3 (or a successor rule
thereto)) of the securities eligible to vote for the election of the Board (“Company Voting Securities”) outstanding immediately prior to the consummation of such Reorganization or Sale continue to beneficially own, directly or
indirectly, more than 50% of the combined voting power of the then outstanding voting securities of the corporation or other entity resulting from such Reorganization or Sale (including a corporation or other entity that, as a result of such
transaction, owns the Company or all or substantially all the Company’s assets either directly or through one or more subsidiaries) (the “Continuing Company”) in substantially the same proportions as their ownership,
immediately prior to the consummation of such Reorganization or Sale, of the outstanding Company Voting Securities (excluding, for such purposes, any outstanding voting securities of the Continuing Company that such beneficial owners hold
immediately following the consummation of the Reorganization or Sale as a result of their ownership prior to such consummation of voting securities of any corporation or other entity 

  
 2 

 
involved in or forming part of such Reorganization or Sale other than the Company), (2) no “person” or “group” (as determined for purposes of Section 13(d)(3) of the
Exchange Act) (excluding any employee benefit plan (or related trust) sponsored or maintained by the Continuing Company or any entity controlled by the Continuing Company) beneficially owns, directly or indirectly, 30% or more of the combined voting
power of the then outstanding voting securities of the Continuing Company and (3) at least a majority of the members of the board of directors of the Continuing Company are Continuing Directors; or 

(iv) approval by the stockholders of the Company of the complete liquidation of the Company. 

(h) “Code” shall mean the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto. 

(i) “Committee” shall mean the Compensation Committee of the Board or such other persons or committee to whom it has
delegated any authority, as may be appropriate. 
 (j) “Company” shall mean Viatris Inc., a Delaware corporation. 

(k) “Director” or “Non-Employee Director” shall mean a member of the
Board. 
 (l) “Dividend Equivalents” are equal to the dividends with respect to a Share of Company stock underlying an
Award. Dividends and Dividend Equivalents that can be earned with respect to an Award may be accumulated, but shall only become payable if and to the extent the underlying Award is vested, and shall be subject to the same restrictions and risk of
forfeiture as the underlying Award. 
 (m) “Dividend Equivalent Units” (“DEUs”) are a credit to an
individual’s Award equivalent to the amount of dividends that would be paid on the same number of actual Shares underlying such Award. “DEUs” are “reinvested” and become additional Awards. Dividends and DEUs that can be
earned with respect to an Award may be accumulated, but shall only become payable if and to the extent the underlying Award is vested, and shall be subject to the same restrictions and risk of forfeiture as the underlying Award. 

(n) “Effective Date” shall mean the date of the Distribution as defined in the BCA. 

(o) “Employee” shall mean any employee of the Company or any Affiliate. 

(p) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 

(q) “Fair Market Value” shall mean, with respect to Shares, as of any date, the closing price for the Shares as reported on
the NASDAQ Global Select Market (or such other national exchange on which the Company maintains its primary listing at such time) for that date or, if no such price is reported for that date, 

  
 3 

 
the closing price on the next preceding date for which such price was reported, unless otherwise determined by the Committee. For purposes of achieving an exemption from Section 409A in the
case of affected Participants governed by Section 409A, Fair Market Value of the Shares shall be determined in a manner consistent with Section 409A and any applicable regulations. 

(r) “Grant Date” shall mean the date on which an Award is granted. 

(s) “Incentive Stock Option” shall mean an Option granted under Section 6 that is intended to meet the requirements of
Section 422 of the Code or any successor provision thereto. 
 (t) “Key Employee” shall mean an Employee treated as a
“specified employee” as of his or her Separation from Service under Section 409A of the Code. Key Employees shall be determined under rules adopted by the Company in accordance with Section 409A. Notwithstanding the foregoing,
the Committee may, under the alternative permissible methods allowable under Section 409A, adopt an alternative identification and effective date for purposes of determining which employees are Key Employees. 

(u) “Nonqualified Stock Option” shall mean either an Option granted under Section 6 that is not intended to be an
Incentive Stock Option or an Incentive Stock Option that has been disqualified. 
 (v) “Option” shall mean any right
granted to a Participant under the Plan allowing such Participant to purchase Shares at such price or prices and during such period or periods as the Committee shall determine. 

(w) “Other Stock Unit Award” shall mean any right granted to a Participant by the Committee pursuant to Section 10. 

(x) “Participant” shall mean an Employee, Non-Employee Director or other Service
Provider who is selected by the Committee, the Board or their authorized designees from time to time in their sole discretion to receive an Award under the Plan. 

(y) “Performance Award” shall mean any Award (which shall include Performance Shares or Performance Cash) granted pursuant to
Section 9, containing performance goals to be achieved as established by the Committee. 
 (z) “Performance Cash”
shall mean any grant pursuant to Section 9 of a cash-denominated award, which value may be paid to the Participant by delivery of such property as the Committee shall determine, including, without limitation, cash, Shares, other property, or
any combination thereof, upon achievement of such performance goals during the Performance Period established by the Committee with respect to such grant. 

(aa) “Performance Period” shall mean a period, as established by the Committee at the time any Performance Award is granted
or at any time thereafter, during which any performance goals specified by the Committee with respect to such Award are to be measured. 

  
 4 

 (bb) “Performance Share Award” or “PSA” shall mean an
award of a Performance Share Units under Section 9. 
 (cc) “Performance Share Units” shall mean any grant pursuant to
Section 9 of a unit valued by reference to a designated number of Shares, which value may be paid to the Participant by delivery of such property as the Committee shall determine, including, without limitation, cash, Shares, other property, or
any combination thereof, upon achievement of such performance goals during the Performance Period established by the Committee with respect to such grant. 

(dd) “Person” shall mean any individual, corporation, partnership, association, limited liability company, joint-stock
company, trust, unincorporated organization or government or political subdivision thereof. 
 (ee) “Restricted Stock”
shall mean any Share issued pursuant to Section 8 with the restriction that the holder may not sell, transfer, pledge or assign such Share and with such other restrictions as the Committee, in its sole and absolute discretion, may impose
(including, without limitation, any restriction on the right to vote such Share, and the right to receive any cash dividends subject to the requirements of Section 2(l) of the Plan), which restrictions may lapse separately or in combination at
such time or times, in installments or otherwise, as the Committee may deem appropriate. 
 (ff) “Restricted Stock Award”
shall mean an award of Restricted Stock under Section 8. 
 (gg) “Restricted Stock Unit” or “RSU”
shall mean any unit issued pursuant to Section 8 representing a Share with such restrictions as the Committee, in its sole and absolute discretion, may impose, which restrictions may lapse separately or in combination at such time or times, in
installments or otherwise, as the Committee may deem appropriate, and which shall have the right to receive DEUs subject to the requirements of Section 2(m) of the Plan as determined by the Committee. 

(hh) “Restricted Stock Unit Award” shall mean an award of Restricted Stock Units under Section 8. 

(ii) “Restriction Period” shall mean the period of time as specified by the Committee, before Restricted Shares, Restricted
Stock Units or Other Stock Unit Awards become non-forfeitable and issuable to a Participant within the meaning of Sections 8 and 10. 

(jj) “Section 409A” shall mean Section 409A of the Code and the regulations and other guidance issued
thereunder by the U.S. Department of the Treasury or Internal Revenue Service. 
 (kk) “Separation from Service” shall mean
a “separation from service” within the meaning of Section 409A. 
 (ll) “Service Provider” shall mean a
consultant or advisor within the meaning of Form S-8 promulgated under the Securities Act of 1933, as amended. 

  
 5 

 (mm) “Shares” shall mean the shares of common stock of the Company. 

(nn) “Stock Appreciation Right” shall mean any right granted to a Participant pursuant to Section 7 to receive, upon
exercise by the Participant, the excess of (i) the Fair Market Value of one Share on the date of exercise over (ii) the grant price of the right on the Grant Date, or if granted in connection with an outstanding Option on the Grant Date of
the related Option, as specified by the Committee in its sole and absolute discretion, which, except in connection with an adjustment provided in Section 4(d), shall not be less than the Fair Market Value of one Share on such Grant Date of the
right or the related Option, as the case may be. Any payment by the Company in respect of such right may be made in cash, Shares, other property, or any combination thereof, as the Committee, in its sole and absolute discretion, shall determine.

 (oo) “Substitute Awards” shall mean Awards granted or Shares issued by the Company in assumption of, or in substitution,
replacement or exchange for, awards previously granted, or the right or obligation to make future awards, by a company acquired by the Company or an Affiliate (or ultimate parent of such company) or with which the Company or an Affiliate combines.

 (pp) “Total and Permanent Disability” shall mean total and permanent disability as determined in accordance with rules
established by the Committee and in compliance with Section 409A. 
 (qq) “Total Shareholder Return Unit” or
“TSRU” shall mean any right granted to a Participant pursuant to Section 7 to receive the excess of (i) the Fair Market Value of one Share on the date of the settlement pursuant to the terms of the grant, over
(ii) the grant price of the right on the Grant Date, as specified by the Committee in its sole and absolute discretion, which, except in connection with an adjustment provided in Section 4(d), shall not be less than the Fair Market Value
of one Share on such Grant Date of the right. Such Total Shareholder Return Unit may or may not accumulate Dividend Equivalents, at the Committee’s discretion. Any payment by the Company in respect of such right may be made in cash or Shares as
the Committee, in its sole and absolute discretion, shall determine. Except with respect to the right to exercise and the accumulation of Dividend Equivalents, for all purposes of this Plan, TSRUs shall be treated the same as Stock Appreciation
Rights. 
 (rr) “Total Shareholder Return Unit Award” shall mean an award of Total Shareholder Return Units under
Section 7. 
 Section 3. Administration. 

(a) The Plan shall be administered by the Committee. The Committee shall have full power and authority, subject to such orders or resolutions
not inconsistent with the provisions of the Plan as may from time to time be adopted by the Board, to (i) select the Employees, Non-Employee Directors or other Service Providers of the Company and its
Affiliates to whom Awards may from time to time be granted hereunder; (ii) determine the type or types of Award to be granted to each Participant hereunder; (iii) determine the number of Shares to be covered by or relating to each Award
granted hereunder; (iv) determine the vesting, exercisability, 

  
 6 

 
transferability, and payment of Awards, including the authority to accelerate the vesting of Awards; (v) determine the terms and conditions, not inconsistent with the provisions of the Plan,
of any Award granted hereunder; (vi) determine whether, to what extent and under what circumstances Awards may be settled in cash, Shares or other property or cancelled or suspended, consistent with the terms of the Plan; (vii) determine
whether, to what extent, and under what circumstances shares or cash paid to or gain realized by the Participant based on an Award shall be returned to the Company, consistent with the terms of the Plan; (viii) determine whether, to what
extent, and under what circumstances a Participant may be ineligible to retain an Award; (ix) determine whether, to what extent, and under what circumstances payment of cash, Shares, other property and other amounts payable with respect to an
Award made under the Plan shall be deferred either automatically or at the election of the Participant, consistent with the terms of the Plan; (x) interpret and administer the Plan and any instrument or agreement entered into under the Plan;
(xi) establish such rules, regulations and sub-plans and appoint such agents as it shall deem appropriate for the proper administration of the Plan; and (xii) make any other determination and take
any other action that the Committee deems necessary or desirable for administration of the Plan. The Committee may, in its sole and absolute discretion, and subject to the provisions of the Plan, from time to time delegate any or all of its
authority to administer the Plan to any other persons or committee as it deems necessary or appropriate for the proper administration of the Plan; provided, however, that in no event shall an employee of the Company be delegated the
authority to grant Awards to, or amend Awards held by, individuals who are subject to Section 16 of the Exchange Act; provided further, that any delegation of administrative authority shall only be permitted to the extent it is
permissible under applicable securities laws or the rules of any securities exchange or automated quotation system on which the Shares are listed, quoted or traded. Any delegation hereunder shall be subject to the restrictions and limits that the
Board or Committee specifies at the time of such delegation. At all times, the delegate appointed under this Section 3 shall serve in such capacity as deemed necessary or desirable by the Committee, in its sole and absolute discretion. The
decisions of the Committee shall be final, conclusive and binding with respect to the interpretation and administration of the Plan and any grants made hereunder. The Committee shall make, in its sole and absolute discretion, all determinations
arising in the administration, construction or interpretation of the Plan and Awards under the Plan, including the right to construe disputed or doubtful Plan or Award terms and provisions, and any such determination shall be conclusive and binding
on all Persons. 
 (b) The Committee shall be authorized to make adjustments in performance criteria or in the terms and conditions of other
Awards in recognition of unusual or nonrecurring events affecting the Company or its financial statements or changes in applicable laws, regulations or accounting principles or as otherwise provided in Section 12. The Committee may correct any
defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem desirable to carry it into effect. In the event that the Company shall assume outstanding employee benefit awards or
the right or obligation to grant future awards in connection with the acquisition of or combination with another corporation or business entity, the Committee may, in its sole and absolute discretion, make such adjustments in the terms of Awards
under the Plan as it shall deem appropriate. The Committee, in its sole and absolute discretion, may, consistent with 

  
 7 

 
the Plan, design any Award to satisfy specific requirements of obtaining a tax, regulatory or accounting benefit or to avoid any adverse tax, regulatory or accounting result; provided,
however, that the Company makes no representation that any Award will satisfy any such particular requirement or achieve any particular result, does not covenant to maintain any particular tax, regulatory or accounting status, and the failure
of any Award to satisfy any such requirement or achieve a particular result shall not create any liability to any Participant or beneficiary. The Committee and each member thereof, shall be indemnified and held harmless to the fullest extent
permitted by law for any and all actions taken pursuant to, and in accordance with, the terms of the Plan. 
 Section 4. Shares
Subject to the Plan. 
 (a) Subject to adjustment as provided in Section 4(c) and Section 4(d),
seventy-two million five hundred thousand (72,500,000) Shares, shall be authorized for grant pursuant to Awards under the Plan (the “Share Limit”), plus any shares underlying awards assumed,
substituted or replaced by the Company in connection with the transactions contemplated by the BCA, provided that no more than the number of Shares equal to the Share Limit may be granted as Incentive Stock Options. No Participant under this
Plan shall be granted Options, TSRUs, Stock Appreciation Rights or other Awards in any consecutive 36-month period covering more than seven million five hundred thousand (7,500,000) Shares. No Participant
under this Plan shall be paid a Performance Cash Award in any calendar year in an amount in excess of fifteen million dollars ($15,000,000). Any Shares issued hereunder may consist, in whole or in part, of authorized and unissued Shares, treasury
Shares or Shares purchased in the open market or otherwise. 
 (b) Notwithstanding any other provision of the Plan to the contrary, any
Awards granted under the Plan (excluding, for this purpose, any (i) Substitute Awards, (ii) Shares delivered in lieu of fully vested cash-denominated Awards and (iii) Awards to Non-Employee
Directors that vest on the earlier of the one year anniversary of the date of grant or the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year’s annual meeting) shall be granted subject to a
minimum vesting period of at least twelve (12) months, such that no such Awards shall vest prior to the first anniversary of the applicable grant date (subject to any accelerated vesting otherwise permitted by the terms of the Plan);
provided, that, the Committee may grant any such Awards without regard to the foregoing minimum vesting requirement (i) with respect to a maximum of five (5) percent of the shares of Common Stock reserved for issuance under the Plan
pursuant to Section 4(a) hereof (subject to adjustment under Section 4(c)) and (ii) on an ad hoc basis in order to achieve a specified business objective, such as an inducement to a new hire or a retention award to a key
employee or group of key employees. 
 (c) In the event of any merger, reorganization, consolidation, recapitalization, stock dividend,
extraordinary cash dividend, stock split, reverse stock split, spin-off, split-off or similar transaction or other change in corporate structure affecting the Shares,
such adjustments and other substitutions shall be made to the Plan and to Awards as the Committee, in its sole and absolute discretion, deems equitable or appropriate, including, without limitation, such adjustments in the aggregate number, class
and kind of securities that may be delivered under the Plan, 

  
 8 

 
in the aggregate or to any one Participant, in the number, class, kind and option or exercise price of securities or other property subject to outstanding Awards granted under the Plan
(including, if the Committee deems appropriate, the substitution of similar options to purchase the shares of, or other awards denominated in the shares of, another company) as the Committee may determine to be appropriate, in its sole and absolute
discretion; provided, however, that the number of Shares subject to any Award shall always be a whole number and further provided that in no event may any change be made to an Incentive Stock Option which would constitute a
modification within the meaning of Section 424(h)(3) of the Code. Moreover, notwithstanding anything herein to the contrary, an adjustment to an Award under this Section 4(c) may not be made in a manner that would result in the grant of a
new Option, TSRU or Stock Appreciation Right under Section 409A, unless the Committee specifically determines that such adjustment is desirable and will not cause the modified award to create adverse tax consequences under Section 409A.

 (d) Any Shares subject to Awards, or Awards assumed, substituted or replaced by the Company in connection with the transactions
contemplated by the BCA, that terminate, expire, or are forfeited, cancelled or settled in cash, either in whole or in part, shall be added to the Shares available for Awards under the Plan to the extent of such termination, forfeiture, cancellation
or settlement. Any Shares that again become available for future grants pursuant to the preceding sentence shall be added back as one (1) Share; provided, however, that such Shares shall not be granted as Incentive Stock Options.
In addition, in the case of any Substitute Award, Shares delivered or deliverable in connection with such assumed or Substitute Award shall not reduce the number of Shares authorized for grant in Section 4(a) above, and Shares subject to a
Substitute Award shall not be added to the Shares available for Awards under the Plan. Additionally, in the event that a company acquired by the Company or any Affiliate or with which the Company or any Affiliate combines has shares available under
a pre-existing plan approved by stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such
pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration
payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the Shares authorized for grant under the Plan (and Shares subject to such Awards shall not
be added to the Shares available for Awards under the Plan); provided that Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the
pre-existing plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees or Directors of the Company prior to such acquisition or combination. Notwithstanding the
foregoing, Shares subject to an Award under the Plan may not again be made available for issuance or delivery under the Plan if such Shares are (i) Shares that were subject to a stock-settled Stock Appreciation Right or TSRU and were not issued
upon the net settlement or net exercise thereof; (ii) Shares delivered to or withheld by the Company to pay the exercise price of an Option; (iii) Shares delivered to or withheld by the Company to pay the withholding taxes relating to an
Award; (iv) Shares withheld by the Company in connection with the net settlement of an Award; or (v) Shares repurchased on the open market with the proceeds of an Option exercise. 

  
 9 

 Section 5. Eligibility. Any Employee,
Non-Employee Director or other Service Provider shall be eligible to be selected as a Participant; provided, however, that Incentive Stock Options shall only be awarded to Employees of the
Company, or a parent or Affiliate, within the meaning of Section 422 of the Code. Notwithstanding any provision in this Plan to the contrary, the Non-Employee Directors, including a designated committee
of the Board composed solely of Non-Employee Directors, shall have the authority, in their sole and absolute discretion, to select Non-Employee Directors as Participants
who are eligible to receive Awards other than Incentive Stock Options under the Plan. The Non-Employee Directors shall set the terms of any such Awards in their sole and absolute discretion, and the Non-Employee Directors shall be responsible for administering and construing such Awards in substantially the same manner that the Committee administers and construes Awards to Employees; provided,
however, that no Non-Employee Directors shall be granted Awards and / or paid a cash retainer in any calendar year under this Plan or any other arrangement with the Company for service in such capacity
having an aggregate value of more than seven hundred and fifty thousand dollars ($750,000). Any compensation that is deferred shall be counted toward this limit for the year in which it was first earned, and not when paid or settled if later. 

Section 6. Stock Options. Options may be granted hereunder to any Participant; either alone or in addition to other Awards granted
under the Plan and shall be subject to the following terms and conditions: 
 (a) Option Price. Other than in connection with
Substitute Awards, the exercise price per Share shall be not less than the Fair Market Value of the Shares on the date the Option is granted. 

(b) Number of Shares. The Option shall state the number of Shares covered thereby. 

(c) Exercise of Option. Unless otherwise determined by the Committee, an Option will be deemed exercised by the optionee, or in the
event of death, an Option shall be deemed exercised by the estate of the optionee, or by a person who acquired the right to exercise such Option by bequest or inheritance or by reason of the death of the optionee, or in the event of the
optionee’s Total and Permanent Disability, an Option shall be deemed exercised by a person having a legally binding power of attorney for the optionee, in each case upon delivery of (i) a notice of exercise to the Company or its
representative, or by using other methods of notice as the Committee shall adopt, and (ii) accompanying payment of the exercise price or other methods of satisfying the exercise price as approved by the Committee and in accordance with any
restrictions as the Committee shall adopt. The notice of exercise, once delivered, shall be irrevocable. Notwithstanding the above, and unless the Committee determines otherwise, in the event that the Option is not exercised by the last day on which
it is exercisable, and the exercise price per Share is below the Fair Market Value of a Share on such date in an amount determined by the Committee or its delegate, the Option shall be deemed exercised on such date, with a spread equal to the Fair
Market Value of the Shares on such date minus the exercise price, and the resulting proceeds net of the exercise price, any required tax withholding (subject to Section 15(j)) and any applicable costs shall be paid to the optionee or the
optionee’s legal representative. In no event may any Option granted hereunder be exercised for a fraction of a Share. 

  
 10 

 (d) Term of Option. The Committee shall determine the term of each Option, except
that the period for Incentive Stock Options shall not exceed ten (10) years from the Grant Date. A Nonqualified Stock Option may be exercisable for a period of up to ten (10) years so as to conform with or take advantage of governmental
requirements, statutes or regulations, but in no event longer than the Option’s term. 
 (e) Termination of Option. All Options
shall terminate upon their expiration, their surrender, upon breach by the optionee of any provisions of the Option, or in accordance with any other rules and procedures incorporated into the terms and conditions governing the Options as the
Committee shall deem advisable or appropriate. 
 (f) Termination of Employment. Except as otherwise set forth in the Plan, the terms
relating to the treatment of an outstanding Option in the event of the Participant’s termination of employment shall be determined by the Committee at the time of grant and shall be set forth in the applicable Award Agreement. 

(g) Incorporation by Reference. The Option shall contain a provision that all the applicable terms and conditions of this Plan are
incorporated by reference therein. 
 (h) Other Provisions. The Option shall also be subject to such other terms and conditions as
the Committee shall deem advisable or appropriate, consistent with the provisions of the Plan as herein set forth. In addition, Incentive Stock Options shall contain such other provisions as may be necessary to meet the requirements of the Code and
the Treasury Department rulings and regulations issued thereunder with respect to Incentive Stock Options. 
 (i) Exemption from
Section 409A. It is intended that all Options granted under this Plan will be exempt from Section 409A. Nevertheless, the Company does not represent, covenant or guarantee that any particular Award made under the Plan
will qualify for favorable tax treatment (e.g., as an Incentive Stock Option) or will avoid unfavorable tax consequences to the Participant (e.g., Section 409A penalties). 

Section 7. Stock Appreciation Rights and Total Shareholder Return Units. 

(a) Grant of a Stock Appreciation Right or Total Shareholder Return Unit (TSRU). Stock Appreciation Rights or TSRUs may be granted
hereunder to any Participant, either alone (“freestanding”) or in addition to other Awards granted under the Plan and may, but need not, relate to a specific Option granted under Section 6. The provisions of Stock Appreciation Rights
or TSRUs need not be the same with respect to each recipient. Any Stock Appreciation Right or TSRU related to a Nonqualified Stock Option may be granted at the same time such Option is granted or at any time thereafter before exercise or expiration
of such Option. Any Stock Appreciation Right or TSRU related to an Incentive Stock Option must be 

  
 11 

 
granted at the same time such Option is granted. In the case of any Stock Appreciation Right or TSRU related to any Option, the Stock Appreciation Right or TSRU or applicable portion thereof
shall terminate and no longer be exercisable upon the termination or exercise of the related Option, except that a Stock Appreciation Right or TSRU granted with respect to less than the full number of Shares covered by a related Option shall not be
reduced until the exercise or termination of the related Option exceeds the number of Shares not covered by the Stock Appreciation Right or TSRU. Any Option related to any Stock Appreciation Right or TSRU shall no longer be exercisable to the extent
the related Stock Appreciation Right or TSRU has been exercised or settled, as applicable. 
 (b) Terms. The Committee may impose
such terms and conditions or restrictions on the exercise of any Stock Appreciation Right or TSRU, as it shall deem advisable or appropriate; provided that a Stock Appreciation Right or TSRU shall not: (i) have an exercise price less
than Fair Market Value of a Share on the Grant Date other than in connection with Substitute Awards; or (ii) a term of greater than ten (10) years. Notwithstanding the above, and unless the Committee determines otherwise, in the event that
the Stock Appreciation Right is not exercised or settled by the last day on which it is exercisable, and the exercise price per share of such Stock Appreciation Right is below the Fair Market Value of a Share on such date in an amount to be
determined by the Committee or its delegate, the Stock Appreciation Right shall be deemed exercised on such date, with a spread equal to the Fair Market Value of the Shares on such date minus the exercise price, and the resulting proceeds net of any
required tax withholding (subject to Section 15(j)) and any applicable costs shall be paid to the Participant or the Participant’s legal representative. 

(c) Termination of Employment. Except as otherwise set forth in the Plan, the terms relating to the treatment of an outstanding Stock
Appreciation Right or TSRU in the event of the Participant’s termination of employment shall be determined by the Committee at the time of grant and shall be set forth in the applicable Award Agreement. 

(d) Section 409A. Stock Appreciation Rights or TSRUs may be granted hereunder by the Committee either (i) in a
manner consistent with Section 409A such that the Stock Appreciation Right or TSRU will not provide for a deferral of compensation under Section 409A, or (ii) in a manner that is intended from grant to subject the Stock Appreciation
Right or TSRU to Section 409A. In the event Stock Appreciation Rights or TSRUs are granted to be so subject to Section 409A, then the Stock Appreciation Right or TSRU shall be settled and paid in a single lump sum (i) as of a
specified date, (ii) upon the Participant’s Separation from Service, or (iii) the earlier of (i) or (ii) hereof, as specified and set forth by the Committee in an Award Agreement at the time of grant, and shall otherwise be
granted, administered, settled and paid in accordance with Section 409A. Notwithstanding the foregoing, to the extent necessary to avoid the imposition of taxes under Section 409A, any such settlement and payment may not be made to a Key
Employee upon a Separation from Service before the date which is 6 months after the date of the Key Employee’s Separation from Service (or, if earlier, the date of death of the Key Employee). 

  
 12 

 Section 8. Restricted Stock and Restricted Stock Units. 

(a) Grant of Restricted Stock or Restricted Stock Unit. A Restricted Stock Award or Restricted Stock Unit Award shall be subject to
restrictions imposed by the Committee at the time of grant for the Restriction Period. Restricted Stock Awards or Restricted Stock Unit Awards may be issued hereunder to Participants for no cash consideration or for such minimum consideration as may
be required by applicable law, either alone or in addition to other Awards granted under the Plan. Any Award of Restricted Stock or a Restricted Stock Unit shall also be subject to such other terms and conditions as the Committee shall deem
advisable or appropriate, consistent with the provisions of the Plan as herein set forth. Unless otherwise provided in the Award Agreement, beginning on the date of grant of the Restricted Stock Award, the Participant shall become a stockholder of
the Company with respect to all Shares subject to the Award Agreement and shall have all of the rights of a stockholder, including the right to vote such Shares and the right to receive distributions made with respect to such Shares, except as
otherwise provided in this Plan. A Participant who holds a Restricted Stock Unit Award shall only have those rights specifically provided for in the Award Agreement; provided, however, in no event shall the Participant have voting
rights with respect to such Award. Dividend Equivalents and DEUs can be earned with respect to the Restricted Stock Unit Awards at the discretion of the Committee. Dividends, Dividend Equivalents or DEUs that can be earned on Restricted Stock Awards
or Restricted Stock Unit Awards, as applicable, may be accumulated, but shall only become payable if and to the extent the underlying Restricted Stock or Restricted Stock Unit Award is vested, and shall be subject to the same restrictions and risk
of forfeiture as the underlying award. 
 (b) Termination of Employment. Except as otherwise set forth in the Plan, the terms
relating to the treatment of an outstanding Restricted Stock Award or Restricted Stock Unit Award in the event of the Participant’s termination of employment shall be determined by the Committee at the time of grant and shall be set forth in
the applicable Award Agreement. 
 (c) Registration. Any Restricted Stock issued hereunder may be evidenced in such manner, as the
Committee, in its sole and absolute discretion, shall deem appropriate, including, without limitation, book entry registration or issuance of a stock certificate or certificates. In the event any stock certificates are issued in respect of Shares of
Restricted Stock awarded under the Plan, such certificates shall be registered in the name of the Participant and shall bear an appropriate legend referring to the terms, conditions and restrictions applicable to such Award. 

(d) Section 409A. Restricted Stock Unit Awards may be granted hereunder by the Committee either (i) in a manner
consistent with Section 409A such that the Restricted Stock Unit Awards will not provide for a deferral of compensation under Section 409A, or (ii) in a manner that is intended from grant to subject the Restricted Stock Unit Awards to
Section 409A. In the event Restricted Stock Unit Awards are granted to be subject to Section 409A, then the Restricted Stock Unit Awards shall be settled and paid in a single lump sum (i) as of a specified date, (ii) upon the
Participant’s Separation from Service, or (iii) the earlier of (i) or (ii) hereof, as specified and set forth by the Committee in an Award Agreement at the time of grant, and shall otherwise be granted, administered, settled and paid
in accordance with Section 409A. Notwithstanding the foregoing, to the extent necessary to avoid 

  
 13 

 
the imposition of taxes under Section 409A, any such settlement and payment may not be made to a Key Employee upon a Separation from Service before the date which is 6 months after the date
of the Key Employee’s Separation from Service (or, if earlier, the date of death of the Key Employee). 
 Section 9.
Performance Awards and Performance Share Awards. 
 (a) Grant of Performance Awards. Performance Awards (which can include
Performance Share Awards and Performance Cash Awards) may be paid in cash, Shares, other property, or any combination thereof, and may be subject to such other terms and conditions as the Committee shall deem advisable or appropriate, consistent
with the provisions of the Plan as set forth, in the sole and absolute discretion of the Committee at the time of payment. The performance levels to be achieved for each Performance Period and the amount of the Award to be distributed shall be
conclusively determined by the Committee. Performance Awards will be paid in a lump sum prior to the 15th day of the third month of the year immediately following the year in which the close of the Performance Period occurs in accordance with the
applicable short-term deferral exception provisions of Section 409A, or, in accordance with procedures established by the Committee and the applicable provisions of Section 409A. Dividend Equivalents that can be earned with respect to
Performance Awards may be accumulated, but shall only become payable if and to the extent the underlying Performance Awards are achieved, and shall be subject to the same restrictions and risk of forfeiture as the underlying award. 

(b) Termination of Employment. Except as otherwise set forth in the Plan, the terms relating to the treatment of an outstanding
Performance Award in the event of the Participant’s termination of employment shall be determined by the Committee at the time of grant and shall be set forth in the applicable Award Agreement. 

(c) Section 409A. In the event Performance Awards are subject to Section 409A, then the Performance Award shall
be settled and paid in a single lump sum (i) as of a specified date, (ii) upon the Participant’s Separation from Service, or (iii) the earlier of (i) or (ii) hereof, in accordance with rules established by the Committee at
the time of grant, and shall otherwise be granted, administered, settled and paid in accordance with Section 409A. Notwithstanding the foregoing, to the extent necessary to avoid the imposition of taxes under Section 409A, any such
settlement and payment may not be made to a Key Employee upon a Separation from Service before the date which is 6 months after the date of the Key Employee’s Separation from Service (or, if earlier, the date of death of the Key Employee). 

Section 10. Other Stock Unit Awards. 

(a) Stock and Administration. Awards that are valued by reference to, or are otherwise based on, Shares may be granted hereunder to
Participants, either alone or in addition to other Awards granted under the Plan, and such Other Stock Unit Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan. Other Stock Unit Awards may be
paid in Shares, cash or any other form of property, as the Committee shall determine. Subject to the provisions of the Plan, the Committee shall have sole and absolute discretion to 

  
 14 

 
determine the Employees to whom and the time or times at which such Awards shall be made, the number of Shares to be issued or delivered pursuant to such Awards, and all other conditions of the
Awards. Any Other Stock Unit Awards shall be subject to such other terms and conditions as the Committee shall deem advisable or appropriate, consistent with the provisions of the Plan as herein set forth. 

(b) Termination of Employment. Except as otherwise set forth in the Plan, the terms relating to the treatment of an outstanding Other
Stock Unit Award in the event of the Participant’s termination of employment shall be determined by the Committee at the time of grant and shall be set forth in the applicable Award Agreement. 

(c) Other Provisions. Shares (including securities convertible into Shares) subject to Awards granted under this
Section 10 may be issued for no cash consideration or for such minimum consideration as may be required by applicable law. 
 (d)
Section 409A. Other Stock Unit Awards may be granted hereunder by the Committee (i) in a manner consistent with Section 409A such that the Other Stock Unit Awards will not provide for a deferral of compensation
under Section 409A, or (ii) in a manner that is intended from grant to subject the Other Stock Unit Award to Section 409A. In the event Other Stock Unit Awards are granted to be subject to Section 409A, then the Other Stock Unit
Awards shall be settled and paid in a single lump sum (i) as of a specified date, (ii) upon the Participant’s Separation from Service, or (iii) the earlier of (i) or (ii) hereof, as specified by the Committee at the time of
grant or otherwise in a fashion which is compliant with Section 409A, and shall otherwise be granted, administered, settled and paid in compliance with Section 409A. Notwithstanding the foregoing, to the extent necessary to avoid the
imposition of taxes under Section 409A, any such settlement and payment may not be made to a Key Employee upon a Separation from Service before the date which is six (6) months after the date of the Key Employee’s Separation from
Service (or, if earlier, the date of death of the Key Employee). 
 Section 11. Change in Control Provisions. 

(a) Unless the Committee or Board shall determine otherwise at the time of grant with respect to a particular Award, and notwithstanding any
other provision of the Plan to the contrary, in the event a Participant’s employment or service is involuntarily terminated by the Company without Cause (as determined by the Committee or Board in its sole and absolute discretion) during the 24-month period following a Change in Control: 
 (i) any Options and Stock Appreciation
Rights outstanding and which are not then exercisable or vested shall upon such involuntary termination fully vest and become exercisable for their full term. TSRUs will continue to vest according to the original vesting schedule at grant and settle
in accordance with the terms of grant. Options, TSRUs and Stock Appreciation Rights shall remain in effect for the respective terms of such Award as set forth in the applicable Award Agreement notwithstanding such involuntary termination; 

  
 15 

 (ii) any vested Options, TSRUs and Stock Appreciation Rights outstanding
shall upon such involuntary termination remain in effect and be exercisable for the respective terms of such Award or settled as applicable, as set forth in the applicable Award Agreement notwithstanding such involuntary termination; 

(iii) any Restricted Stock Unit shall upon such involuntary termination fully vest and be settled at the time of such
termination; 
 (iv) all Performance Awards, Performance Share Awards and Performance Cash Awards shall upon such involuntary
termination continue to vest according to the original vesting and distribution schedule at grant and will be paid at the end of the performance period based on the applicable performance criteria; 

(v) the restrictions applicable to any Restricted Stock shall upon such involuntary termination lapse, and such Restricted
Stock shall immediately become free of all restrictions, limitations or conditions and become fully vested and transferable to the full extent of the original grant; 

(vi) any Other Stock Unit Awards or any other Awards shall upon such involuntary termination continue to vest and be paid
according to the original vesting and distribution schedule at grant; and 
 (vii) notwithstanding any other provision of
this Section 11(a), the proceeds, from exercise, settlement or otherwise, of any Options, Stock Appreciation Rights, TSRUs, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Share Awards or Other Stock Unit Awards that
are considered deferred compensation under Section 409A shall be subject to the terms of Section 18 of the Plan. 
 (b) Change
in Control Cash Out. Notwithstanding any other provision of the Plan, in the event of a Change in Control, or, with respect to Options, TSRUs, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Awards, Performance
Share Awards, Performance Cash Awards or Other Stock Unit Awards that are considered deferred compensation under Section 409A, in the event of a Change in Control that is also a “Change in Control Event” described in
Section 409A(a)(2)(A)(v) or otherwise under Section 409A, the Committee or Board may, in its sole and absolute discretion, provide that such Awards shall, upon the occurrence of a Change in Control, be cancelled in exchange for a payment
to be made within 60 days of the Change in Control (and the Participant shall have no discretion to choose the date of payment): (A) in an amount equal to the amount by which the Fair Market Value per Share on the date of the payment exceeds
the option price per Share under the Option, if any, multiplied by the number of Shares to be issued and delivered under the Option; (B) in an amount equal to the value of the TSRUs (change in stock price plus projected dividend equivalents,
multiplied by the number of the TSRUs granted); (C) in an amount equal to the value of the Stock Appreciation Rights (change in stock price multiplied by the number of the Stock Appreciation Rights granted); or (D) in an amount equal to the
Fair Market Value per Share on the date of the payment for the Restricted Stock, Restricted Stock Units, Performance 

  
 16 

 
Awards, Performance Share Awards or Other Stock Unit Awards. However, if the option price per Share under any outstanding Option is equal to or greater than the Fair Market Value per Share, or
the value (change in stock price plus projected dividend equivalents) of any outstanding TSRU or the value (change in stock price) of any outstanding Stock Appreciation Right is negative, the Board may cancel such Award without the payment of any
consideration. For the avoidance of doubt, the Committee or Board may, in its sole and absolute discretion, determine the appropriate treatment of Awards upon a Change in Control. 

(c) Notwithstanding the above, if the Change in Control is the result of a transaction pursuant to Section 2(g)(iii) and the surviving
entity does not assume, substitute or replace Awards, such Awards shall become fully vested and, (except with respect to TSRUs unless exercisable by their terms), immediately exercisable or transferable to the full extent of the original grant upon
the Change in Control and shall be distributed, settled or paid in full within 60 days of the Change in Control as provided in Section 11(b) above with respect to each Award that is intended to be exempt from Section 409A, and, provided
that such Change in Control is a “Change in Control Event” described in Section 409A(a)(2)(A)(v) or otherwise under Section 409A each Award that is considered deferred compensation under Section 409A, respectively. 

Section 12. Performance Goals. 

(a) If an Award is designated by the Committee as subject to this Section 12, then the lapsing of restrictions thereon and the
distribution of cash, Shares or other property pursuant thereto, as applicable, may be subject to the achievement of one or more objective performance goals established by the Committee, which shall be based on the attainment of specified levels of
one or any combination of the following: (i) shareholder return; (ii) total shareholder return (whether absolute or relative); (iii) cost targets or reductions, savings, productivity or efficiencies; (iv) operating income, income
before or after taxes, net income, or adjusted net income; (v) earnings per share, adjusted earnings per share, earnings before or after taxes, earnings before or after interest, depreciation and/or amortization (“EBITDA”),
adjusted EBITDA, economic earnings, or extraordinary or special items or book value per share (which may exclude nonrecurring items); (vi) operating profit or margins or operating expenses, (vii) working capital measures; (viii) return on
assets (gross or net), return on equity or return on invested capital; (ix) cash flow or balance sheet measures; (x) market share; (xi) revenues; (xii) strategic business criteria, consisting of one or more objectives based on meeting
specified market penetration, geographic business expansion, and goals relating to acquisitions, divestitures, joint ventures and similar transactions, and budget comparisons; (xiii) personal professional objectives, including any of the
foregoing performance goals, the implementation of policies and plans, the negotiation of transactions, formation of joint ventures, research or development collaborations, and the completion of other corporate transactions and any combination of,
or a specified increase in, any of the foregoing; (xiv) economic value added to the Company or the Affiliate or division of the Company for or within which the Participant is primarily employed; or (xv) such other criteria established by
the Committee. Where applicable, the Performance Goals may be expressed in terms of attaining a specified level of the particular criteria or the attainment of any or a specific percentage 

  
 17 

 
increase or decrease in the particular criteria. Such performance goals also may be based on the achievement of specified levels of Company performance (or performance of an applicable Affiliate
or division of the Company) under one or more of the measures described above relative to the performance of other corporations. The Committee shall have the authority to make equitable adjustments to the Performance Goals as may be determined by
the Committee, in its sole and absolute discretion. 
 Section 13. Amendments and Termination. 

(a) The Board may amend, alter, suspend, discontinue or terminate the Plan or any portion thereof at any time; provided, however,
that no such amendment, alteration, suspension, discontinuation or termination shall be made without (i) stockholder approval if such approval is necessary to qualify for or comply with any tax or regulatory requirement or in order to satisfy
any rules of the stock exchange on which the Shares are traded or other applicable law for which the Board deems it necessary or desirable to qualify, satisfy or comply, or (ii) the consent of the affected Participant, if such action would
materially impair the rights of such Participant under any outstanding Award. Notwithstanding anything in the Plan to the contrary, the Board may not (except pursuant to Section 4(c) or in connection with a Change in Control), without the
approval of the Company’s stockholders, cancel an Option, TSRU or Stock Appreciation Right in exchange for cash and may not add the shares underlying a canceled Option, TSRU or Stock Appreciation Right to the Shares available for Awards under
the Plan, when the exercise or grant price per share exceeds the Fair Market Value of one Share or take any action with respect to an Option, TSRU or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of
the principal securities exchange on which the Shares are traded, including a reduction of the exercise price of an Option or the grant price of a TSRU or Stock Appreciation Right or the exchange of an Option, TSRU or Stock Appreciation Right for
another Award. In addition, notwithstanding the above, any termination of the Plan shall comply with Section 409A to the extent necessary in order to avoid adverse tax consequences to Participants under Section 409A. 

(b) The Committee may delegate to another committee, as it may appoint, the authority to take any action consistent with the terms of the
Plan, either before or after an Award has been granted, which such other committee deems necessary or advisable to comply with any government laws or regulatory requirements of a foreign country or for local tax reasons or reasons of local custom,
including but not limited to, modifying or amending the terms and conditions governing any Awards, or establishing any local country plans as sub-plans to this Plan. In addition, under all circumstances, the
Committee may make non-substantive administrative changes to the Plan as to conform with or take advantage of governmental requirements, statutes or regulations. 

(c) The Committee may amend the terms of any Award theretofore granted, prospectively or retroactively, but no such amendment shall
(i) unless otherwise required or advisable under applicable law (as determined by the Board), materially impair the rights of any Participant without his or her consent, or (ii) cause any Award intended to be exempt from Section 409A
to become subject to Section 409A. Notwithstanding the foregoing, the Committee may amend the terms of any 

  
 18 

 
award heretofore granted, prospectively or retroactively, in order to cure any potential defects under Section 409A, in a manner deemed appropriate by the Committee in its sole and absolute
discretion, without the consent of the Participant. Any change or adjustment to an outstanding Incentive Stock Option shall not, without the consent of the Participant, be made in a manner so as to constitute a “modification” that would
cause such Incentive Stock Option to fail to continue to qualify as an Incentive Stock Option. Notwithstanding the foregoing, any adjustments made pursuant to Section 4(c) shall not be subject to these restrictions. 

Section 14. Dividends. Subject to the provisions of the Plan and any Award Agreement, the recipient of an Award (including,
without limitation, any deferred Award) may, if so determined by the Committee, be entitled to receive, cash or stock dividends, or Dividend Equivalents with respect to the number of Shares covered by the Award, as determined by the Committee, in
its sole and absolute discretion, and the Committee may provide that such amounts (if any) shall be deemed to have been reinvested in additional Shares or otherwise reinvested; provided, however, that dividends and or Dividend
Equivalents that can be earned with respect to an Award, shall only become payable if and to the extent the underlying Award vests, regardless of whether or not vesting is contingent upon the achievement of performance goals or time and
provided further, however, that if the receipt of any such Dividend Equivalents granted with respect to Options, TSRUs, Restricted Stock, Other Stock Unit Awards and Stock Appreciation Rights is contingent upon the exercise of
the Options or TSRUs or Stock Appreciation Right, or the vesting of the Restricted Stock, Performance Shares, or Other Stock Unit Awards, then the Options, Restricted Stock, Performance Shares, Other Stock Unit Awards, or Stock Appreciation Rights
shall be granted and administered in accordance with all applicable provisions of Section 409A. 
 Section 15. General
Provisions. 
 (a) An Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by
will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant; provided that the Committee, in its sole and absolute discretion, may permit additional transferability, on a
general or specific basis, other than to a third party for consideration, and may impose conditions and limitations on any permitted transferability. 

(b) No Employee, Non-Employee Director or other Service Provider shall have the right to be selected
to receive an Award under this Plan or, having been so selected, to be selected to receive a future Award grant. Neither the Award nor any benefits arising out of this Plan shall constitute part of a Participant’s employment or service contract
with the Company or any Affiliate and, accordingly, this Plan and the benefits hereunder may be terminated at any time in the sole and absolute discretion of the Company without giving rise to liability on the part of the Company or any Affiliate
for severance payments. The Awards under this Plan are not intended to be treated as compensation for any purpose including under any other Company plan. 

  
 19 

 (c) No Employee, Non-Employee Director or other
Service Provider shall have any claim to be granted any Award under the Plan, and there is no obligation for uniformity of treatment of Employees or Participants under the Plan. 

(d) The prospective recipient of any Award under the Plan shall not, with respect to such Award, be deemed to have become a Participant, or to
have any rights with respect to such Award until and unless such recipient shall have accepted any Award Agreement or other instrument evidencing the Award. 

(e) Nothing in the Plan or any Award granted under the Plan shall be deemed to constitute an employment or service contract or confer or be
deemed to confer on any Employee or Participant any right to continue in the employ or service of, or to continue any other relationship with, the Company or any Affiliate or limit in any way the right of the Company or any Affiliate to terminate an
Employee’s employment or Participant’s service at any time, with or without Cause. 
 (f) All Shares delivered under the Plan
pursuant to any Award shall be subject to such stock transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange upon
which the Shares are then listed, and any applicable federal, state or local securities law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. 

(g) Awards are subject to the Company’s policies on recoupment of gains realized from any Awards as may be in effect from time to time.
All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the
Company’s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. 

(h) No Award granted hereunder shall be construed as an offer to sell securities of the Company, and no such offer shall be outstanding,
unless and until the Committee in its sole and absolute discretion has determined that any such offer, if made, would comply with all applicable requirements of the U.S. federal securities laws and any other laws to which such offer, if made, would
be subject. 
 (i) Except as otherwise required in any applicable Award Agreement or by the terms of the Plan, recipients of Awards under
the Plan shall not be required to make any payment or provide consideration other than the rendering of services. 
 (j) The Company and its
Affiliates shall be authorized to withhold from any Award granted or payment due under the Plan, and/or to withhold from wages or other cash compensation paid to the Participant, the amount of withholding taxes due in respect of an Award or payment
hereunder and to take such other action as may be necessary in the opinion of the Company or Affiliate to satisfy all obligations for the payment of such taxes. Such other actions may include, without limitation, the requirement that the Participant
execute a market sale of Shares or other consideration received pursuant to the Award. The Committee shall be authorized to establish procedures for elections by Participants to satisfy such 

  
 20 

 
obligation for the payment of such taxes by delivery of or transfer of Shares to the Company (in a manner limited so as to avoid adverse accounting treatment for the Company), or by directing the
Company to retain Shares with a value not to exceed the maximum statutory rate of the Participant’s applicable jurisdiction(s) or otherwise deliverable in connection with the Award with a value at the Participant’s minimum statutory
required tax withholding rate (up to the maximum statutory tax rate) of the Participant’s applicable jurisdiction(s) (in a manner limited so as to avoid adverse accounting treatment for the Company and permitted under applicable withholding
rules promulgated by the Internal Revenue Service or other applicable governmental entity). 
 (k) Nothing contained in the Plan shall
prevent the Board from adopting other or additional compensation arrangements, subject to stockholder approval if such approval is required; and such arrangements may be either generally applicable or applicable only in specific cases. 

(l) Any Award shall contain a provision that it may not be exercised at a time when the exercise thereof or the issuance of Shares thereunder
would constitute a violation of any federal or state law or listing requirements of any stock exchange upon which the Shares are then listed or a violation of any foreign jurisdiction where Awards are or will be granted under the Plan. Without
limiting the foregoing, the Company shall have no obligation to issue or deliver Shares subject to Awards granted hereunder prior to: (i) obtaining any approvals from governmental agencies that the Company determines are necessary or advisable,
and (ii) completion of any registration or other qualification with respect to the Shares under any applicable law in the United States or any jurisdiction outside of the United States or ruling of any governmental body that the Company
determines to be necessary or advisable or at a time when such registration or qualification is not current, has been suspended or otherwise has ceased to be effective. The inability or impracticability of the Company to obtain or maintain authority
from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to
issue or sell such Shares as to which such requisite authority shall not have been obtained, and shall constitute circumstances in which the Committee may determine to amend or cancel awards pertaining to such Shares, with or without consideration
to the affected Participants. 
 (m) The provisions of the Plan shall be construed, regulated and administered according to the laws of the
Commonwealth of Pennsylvania without giving effect to principles of conflicts of law, except to the extent superseded by any controlling federal statute. 

(n) The Committee may amend the terms of any Award heretofore granted, prospectively or retroactively, in order to cure any potential defects
under Section 409A, in a manner deemed appropriate by the Committee in its sole and absolute discretion, without the consent of the Participant. Nothing in this Section 15(n) shall be construed as an admission that any of the compensation
and/or benefits payable under this Plan constitutes “deferred compensation” subject to Section 409A. 

  
 21 

 (o) If any provision of the Plan is or becomes or is deemed invalid, illegal or
unenforceable in any jurisdiction, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to applicable laws or if it cannot be construed or deemed
amended without, in the determination of the Committee, materially altering the intent of the Plan, it shall be stricken and the remainder of the Plan shall remain in full force and effect. 

(p) Awards may be granted to Participants who are foreign nationals or employed outside the United States, or both, on such terms and
conditions different from those applicable to Awards to Employees employed in the United States as may, in the judgment of the Committee, be necessary or desirable in order to recognize differences in local law or tax policy. The Committee also may
impose conditions on the exercise or vesting of Awards in order to minimize the Company’s obligation with respect to tax equalization for Employees on assignments outside their home country. 

(q) If approved by the Committee in its sole and absolute discretion, an Employee’s absence or leave because of military or governmental
service, Total and Permanent Disability or other reason shall not be considered an interruption of employment for any purpose under the Plan; provided, however, that to the extent an Award under this Plan is subject to
Section 409A, such absence or leave shall be considered a Separation from Service to the extent provided by Section 409A. 

Section 16. Term of Plan. The Plan shall terminate on the tenth anniversary of the Effective Date, unless sooner terminated by the
Board pursuant to Section 13; provided, however, in no event may an Incentive Stock Option be granted more than ten (10) years after the Effective Date. 

Section 17. Compliance with Section 16. With respect to Participants subject to Section 16 of the Exchange
Act (“Members”), transactions under the Plan are intended to comply with all applicable conditions of Rule 16b-3 or its successors under the Exchange Act. To the extent that compliance with
any Plan provision applicable solely to such Members that is included solely for purposes of complying with Rule 16b-3 is not required in order to bring a transaction by such Member in compliance with Rule 16b-3, it shall be deemed null and void as to such transaction, to the extent permitted by law and deemed advisable by the Committee. To the extent any provision in the Plan or action by the Committee involving such
Members is deemed not to comply with an applicable condition of Rule 16b-3, it shall be deemed null and void as to such Members, to the extent permitted by law and deemed advisable by the Committee. 

Section 18. Compliance with Section 409A. The intent of the parties is that payments and benefits under the
Plan comply with Section 409A to the extent subject thereto or an exemption therefrom, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and be administered to be in compliance therewith. Any payments described in
the Plan that are due within the “short-term deferral period” as defined in Section 409A shall not be treated as deferred compensation unless applicable law requires otherwise. Notwithstanding anything to the contrary in the Plan, no
payment or distribution under this Plan that constitutes an 

  
 22 

 
item of deferred compensation under Section 409A and becomes payable by reason of a Participant’s termination of employment or service with the Company will be made to such Participant
until such Participant’s termination of employment or service constitutes a Separation from Service. Notwithstanding anything to the contrary in the Plan, to the extent required in order to avoid accelerated taxation and/or tax penalties under
Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided during the six (6) month period immediately following the Participant’s termination of employment shall instead be paid on the first
business day after the date that is six (6) months following the Participant’s separation from service (or upon the Participant’s death, if earlier). In addition, for purposes of the Plan, each amount to be paid or benefit to be
provided to the Participant pursuant to the Plan, which constitutes deferred compensation subject to Section 409A, shall be construed as a separate identified payment for purposes of Section 409A. For any payment under the Plan that
constitutes deferred compensation under Section 409A, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section 409A, a Change in Control shall be deemed to have occurred under the Plan with respect
to such payment only if a change in the ownership or effective control of the Company or a change in ownership of a substantial portion of the assets of the Company shall also be deemed to have occurred under Section 409A. The Company makes no
representation that any or all of the payments or benefits described in this Plan will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment. The Participant shall be
solely responsible for the payment of any taxes and penalties incurred under Section 409A. 

  
 23EX-4.6

 Exhibit 4.6 

THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER
THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION
REQUIREMENTS OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE, TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS. THIS WARRANT MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY. 

WARRANT TO PURCHASE SHARES OF COMMON STOCK 

of 
 DERMTECH, INC.

 Dated as of February 4, 2020 

(the “Issue Date”) 

Void after the date specified in Section 8 
  

					
	 No. PA-Series C
[            ]
	  	 Warrant to Purchase

Shares of Common Stock
	  	

 THIS CERTIFIES THAT, for value received,
[                    ], or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms
and conditions set forth herein, to purchase from DermTech, Inc., a Delaware corporation (the “Company”) shares of the Company’s Common Stock (the “Shares”) in the amounts, at such times and at
the price per share set forth in Section 1. The term “Warrant” as used herein shall include this Warrant and any warrants delivered in substitution or exchange therefor as provided herein 

The following is a statement of the rights of the Holder and the conditions to which this Warrant is subject, and to which Holder, by
acceptance of this Warrant, agrees: 
 1.    Number and Price of Shares; Exercise Period. 

(a)    Number of Shares. Subject to any previous exercise of the Warrant, the Holder shall have the right to
purchase up to [                ] Shares, as may be adjusted pursuant hereto, prior to (or in connection with) the expiration of this Warrant as provided in
Section 8. 
 (b)    Exercise Price. The exercise price per Share shall be equal to $9.54, subject to
adjustment pursuant hereto (the “Exercise Price”). 
 (c)    Exercise Period. This
Warrant shall be exercisable, in whole or in part, prior to (or in connection with) the expiration of this Warrant as set forth in Section 8. 

2.    Exercise of the Warrant. 

(a)    Exercise. The purchase rights represented by this Warrant may be exercised at the election of the
Holder, in whole or in part, in accordance with Section 1, by: 
 (i)    the tender to the Company at its
principal office (or such other office or agency as the Company may designate) of a notice of exercise in the form of Exhibit A (the “Notice of Exercise”), duly completed and executed by or on behalf of the Holder,
together with the surrender of this Warrant; and 

 (ii)    the payment to the Company of an amount equal to (x) the
Exercise Price multiplied by (y) the number of Shares being purchased, by (a) wire transfer or certified, cashier’s or other check acceptable to the Company and payable to the order of the Company; (b) surrender and cancellation
of promissory notes or other instruments representing indebtedness of the Company to the Holder; or (c) a combination of (a) and (b). 

(b)    Net Issue Exercise. In lieu of exercising this Warrant pursuant to Section 2(a)(ii), if the fair
market value of one Share is greater than the Exercise Price (at the date of calculation as set forth below), the Holder may elect to receive a number of Shares equal to the value of this Warrant (or of any portion of this Warrant being canceled) by
surrender of this Warrant at the principal office of the Company (or such other office or agency as the Company may designate) together with a properly completed and executed Notice of Exercise reflecting such election, in which event the Company
shall issue to the Holder that number of Shares computed using the following formula: 
  

					
		 		  	       X
            =            Y (A – B)

                          
                 A

			
	Where:	 		  	
			
	X	 	=	  	The number of Shares to be issued to the Holder
			
	Y	 	=	  	The number of Shares purchasable under this Warrant or, if a portion of the Warrant is being exercised, the portion of the Warrant being canceled (at the date of such calculation)
			
	A	 	=	  	The fair market value of one Share (at the date of such calculation)
			
	B	 	=	  	The Exercise Price (as adjusted to the date of such calculation)

 For purposes of the calculation above, the fair market value of one Share shall be determined by the
Board of Directors of the Company, acting in good faith; provided, however, that where a public market exists for the Company’s common stock at the time of such exercise, the fair market value per Share shall be the closing bid price of the
common stock or the closing price quoted on the national securities exchange on which the common stock is listed, as applicable, on the first trading day preceding the date of determination of fair market value. 

(c)    Book Entry Position. The rights under this
Warrant shall be deemed to have been exercised and the Shares issuable upon such exercise shall be deemed to have been issued immediately prior to the close of business on the date this Warrant is exercised in accordance with its terms, and the
person entitled to receive the Shares issuable upon such exercise shall be treated for all purposes as the holder of record of such Shares as of the close of business on such date. As promptly as reasonably practicable on or after such date, and in
any event within fifteen (15) days thereafter, the Company shall cause to be recorded with the Company’s transfer agent, a book entry position evidencing the number of Shares issuable upon such exercise in the name(s) of the person or
persons entitled to such Shares. In the event that the rights under this Warrant are exercised in part and have not expired, the Company shall execute and deliver a new Warrant reflecting the number of Shares that remain subject to this Warrant.

 (d)    No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of the rights under this Warrant. In lieu of such fractional share to which the Holder would otherwise be entitled, the Company shall make a cash payment equal to the Exercise Price multiplied by such fraction. 

(e)    Conditional Exercise. The Holder may exercise this Warrant conditioned upon (and effective
immediately prior to) consummation of any transaction that would cause the expiration of this Warrant pursuant to Section 8 by so indicating in the notice of exercise. 

(f)    Reservation of Stock. The Company agrees during the term the rights under this Warrant are
exercisable to take all reasonable action to reserve and keep available from its authorized and unissued shares of Common Stock for the purpose of effecting the exercise of this Warrant such number of shares (and shares of common

  
 2 

 
stock for issuance on conversion of such shares) as shall from time to time be sufficient to effect the exercise of the rights under this Warrant; and if at any time the number of authorized but
unissued shares of Common Stock (and shares of common stock for issuance on conversion of such shares) shall not be sufficient for purposes of the exercise of this Warrant in accordance with its terms and the conversion of the Shares, without
limitation of such other remedies as may be available to the Holder, the Company will use all reasonable efforts to take such corporate action as may, in the opinion of counsel, be necessary to increase its authorized and unissued shares of its
Common Stock (and shares of common stock for issuance on conversion of such shares) to a number of shares as shall be sufficient for such purposes. 

3.    Replacement of the Warrant. Subject to the receipt of evidence reasonably satisfactory to the Company
of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company or, in the case of mutilation, on
surrender and cancellation of this Warrant, the Company at the expense of the Holder shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. 

4.    Transfer of the Warrant. 

(a)    Warrant Register. The Company shall maintain a register (the “Warrant
Register”) containing the name and address of the Holder or Holders. Until this Warrant is transferred on the Warrant Register in accordance herewith, the Company may treat the Holder as shown on the Warrant Register as the absolute
owner of this Warrant for all purposes, notwithstanding any notice to the contrary. Any Holder of this Warrant (or of any portion of this Warrant) may change its address as shown on the Warrant Register by written notice to the Company requesting a
change. 
 (b)    Warrant Agent. The Company may appoint an agent for the purpose of maintaining the
Warrant Register referred to in Section 4(a), issuing the Shares or other securities then issuable upon the exercise of the rights under this Warrant, exchanging this Warrant, replacing this Warrant or conducting related activities. 

(c)    Transferability of the Warrant. Subject to the provisions of this Warrant with respect to compliance
with the Securities Act of 1933, as amended (the “Securities Act”) and limitations on assignments and transfers, including without limitation compliance with the restrictions on transfer set forth in Section 5, title to
this Warrant may be transferred by endorsement (by the transferor and the transferee executing the assignment form attached as Exhibit B (the “Assignment Form”)) and delivery in the same manner as a negotiable
instrument transferable by endorsement and delivery. 
 (d)    Exchange of the Warrant upon a Transfer. On
surrender of this Warrant (and a properly endorsed Assignment Form) for exchange, subject to the provisions of this Warrant with respect to compliance with the Securities Act and limitations on assignments and transfers, the Company shall issue to
or on the order of the Holder a new warrant or warrants of like tenor, in the name of the Holder or as the Holder (on payment by the Holder of any applicable transfer taxes) may direct, for the number of shares issuable upon exercise hereof, and the
Company shall register any such transfer upon the Warrant Register. This Warrant (and the securities issuable upon exercise of the rights under this Warrant) must be surrendered to the Company or its warrant or transfer agent, as applicable, as a
condition precedent to the sale, pledge, hypothecation or other transfer of any interest in any of the securities represented hereby. 

(e)    Taxes. In no event shall the Company be required to pay any tax which may be payable in respect of
any transfer involved in the issue and delivery of any certificate or recording of any book entry position in a name other than that of the Holder, and the Company shall not be required to issue or deliver any such certificate or record any book
entry position unless and until the person or persons requesting the issue or recording thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid or is not
payable. 

  
 3 

 5.    Restrictions on Transfer of the Warrant and Shares;
Compliance with Securities Laws. By acceptance of this Warrant, the Holder agrees to comply with the following: 

(a)    Restrictions on Transfers. Subject to Section 5(b), this Warrant may not be transferred or
assigned in whole or in part without the Company’s prior written consent (which shall not be unreasonably withheld), and any attempt by Holder to transfer or assign any rights, duties or obligations that arise under this Warrant without such
permission shall be void. Any transfer of this Warrant, the Shares or the common stock issuable upon the conversion of the Shares (the “Securities”) must be in compliance with all applicable federal and state securities laws.
The Holder agrees not to make any sale, assignment, transfer, pledge or other disposition of all or any portion of the Securities, or any beneficial interest therein, unless and until the transferee thereof has agreed in writing for the benefit of
the Company to take and hold such Securities subject to, and to be bound by, the terms and conditions set forth in this Warrant, to the same extent as if the transferee were the original Holder hereunder, and 

(i)    there is then in effect a registration statement under the Securities Act covering such proposed disposition and
such disposition is made in accordance with such registration statement, or 
 (ii)    (A) such Holder shall have
given prior written notice to the Company of such Holder’s intention to make such disposition and shall have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, (B) the transferee
shall have confirmed to the satisfaction of the Company in writing, substantially in the form of Exhibit A-1, that the Securities are being acquired (i) solely for the transferee’s own account
and not as a nominee for any other party, (ii) for investment and (iii) not with a view toward distribution or resale, and shall have confirmed such other matters related thereto as may be reasonably requested by the Company, and
(C) if requested by the Company, such Holder shall have furnished the Company, at the Holder’s expense and option, either (i) evidence reasonably satisfactory to the Company that such disposition will not require registration of such
Securities under the Securities Act or (ii) a “no action” letter from the Securities and Exchange Commission to the effect that the transfer of such Securities without registration will not result in a recommendation by the staff of
the Securities and Exchange Commission that action be taken with respect thereto, whereupon such Holder shall be entitled to transfer such Securities in accordance with the terms of the notice delivered by the Holder to the Company. It is agreed
that the Company will not require opinions of counsel for transactions made pursuant to Rule 144 except in unusual circumstances. 

(b)    Permitted Transfers. Permitted transfers include (i) a transfer not involving a change in
beneficial ownership, or (ii) transactions involving the distribution without consideration of Securities by any Holder to (w) such Holder’s child, step-child, grandchild, parent, step-parent, grandparent, spouse, sibling, mother-in-law, father-in-law,
son-in-law, daughter-in-law, sister-in-law or brother-in-law, or a trust for the benefit of any such family member, (x) a parent, subsidiary or other
affiliate of a Holder that is a corporation, limited liability company or limited partnership (y) any of the Holder’s partners, members or other equity owners, or retired partners or members, or to the estate of any of its partners,
members or other equity owners or retired partners or members, or (z) any venture capital or other investment fund now or hereafter existing that is controlled by or under common control with one or more general partners of or that shares the
same management company or investment advisor with such Holder; provided, in each case, that the Holder shall give written notice to the Company of the Holder’s intention to effect such disposition and shall have furnished the Company
with a detailed description of the manner and circumstances of the proposed disposition. 
 (c)    Investment
Representation Statement. Unless the rights under this Warrant are exercised pursuant to an effective registration statement under the Securities Act that includes the Shares with respect to which the Warrant was exercised, it shall be a
condition to any exercise of the rights under this Warrant that the Holder shall have confirmed to the satisfaction of the Company in writing, substantially in the form of Exhibit A-1, that the Shares so
purchased are being acquired solely for the Holder’s own account and not as a nominee for any other party, for investment and not with a view toward distribution or resale and that the Holder shall have confirmed such other matters related
thereto as may be reasonably requested by the Company. 

  
 4 

 (d)    Securities Law Legend. The Securities shall (unless
otherwise permitted by the provisions of this Warrant) be stamped or imprinted with a legend substantially similar to the following (in addition to any legend required by state securities laws): 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE
SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION
REQUIREMENTS OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS. THIS CERTIFICATE MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY. 

(e)    Instructions Regarding Transfer Restrictions. The Holder consents to the Company making a notation on
its records and giving instructions to any transfer agent in order to implement the restrictions on transfer established in this Section 5. 

(f)    Removal of Legend. The legend referring to federal and state securities laws identified in
Section 5(d) stamped on a certificate evidencing the Shares and the stock transfer instructions and record notations with respect to such securities shall be removed and the Company shall issue a certificate or record a book entry position
without such legend for the holder of such securities if (i) such securities are registered under the Securities Act, or (ii) such holder provides the Company with an opinion of counsel reasonably acceptable to the Company to the effect
that a sale or transfer of such securities may be made without registration or qualification. 
 (g)    No
Transfers to Bad Actors; Notice of Bad Actor Status. The Holder agrees not to sell, assign, transfer, pledge or otherwise dispose of any securities of the Company, or any beneficial interest therein, to any person (other than the
Company) unless and until the proposed transferee confirms to the reasonable satisfaction of the Company that neither the proposed transferee nor any of its directors, executive officers, other officers that may serve as a director or officer of any
company in which it invests, general partners or managing members nor any person that would be deemed a beneficial owner of those securities (in accordance with Rule 506(d) of the Securities Act) is subject to any of the “bad actor”
disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act, except as set forth in Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and disclosed, reasonably in advance of the transfer,
in writing in reasonable detail to the Company. The Holder will promptly notify the Company in writing if the Holder or, to the Holder’s knowledge, any person specified in Rule 506(d)(1) under the Securities Act becomes subject to any of
the “bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act. 

6.    Adjustments. Subject to the expiration of this Warrant pursuant to Section 8, the number and kind
of shares purchasable hereunder and the Exercise Price therefor are subject to adjustment from time to time, as follows: 

(a)    Merger or Reorganization. If at any time there shall be any reorganization, recapitalization, merger
or consolidation (a “Reorganization”) involving the Company (other than as otherwise provided for herein or as would cause the expiration of this Warrant under Section 8) in which shares of the Company’s stock are
converted into or exchanged for securities, cash or other property, then, as a part of such Reorganization, lawful provision shall be made so that the Holder shall thereafter be entitled to receive upon exercise of this Warrant, the kind and amount
of securities, cash or other property of the successor corporation resulting from such Reorganization, equivalent in value to that which a holder of the Shares deliverable upon exercise of this Warrant would have been entitled in such Reorganization
if the right to purchase the Shares hereunder had been exercised immediately prior to such Reorganization. In any such case, appropriate adjustment (as determined in good faith by the Board of Directors of the successor corporation) shall be made in
the application of the provisions of this Warrant with respect to the rights and interests of the Holder after such 

  
 5 

 
Reorganization to the end that the provisions of this Warrant shall be applicable after the event, as near as reasonably may be, in relation to any shares or other securities deliverable after
that event upon the exercise of this Warrant. 
 (b)    Reclassification of Shares. If the securities
issuable upon exercise of this Warrant are changed into the same or a different number of securities of any other class or classes by reclassification, capital reorganization or otherwise (other than as otherwise provided for herein) (a
“Reclassification”), then, in any such event, in lieu of the number of Shares which the Holder would otherwise have been entitled to receive, the Holder shall have the right thereafter to exercise this Warrant for a number of
shares of such other class or classes of stock that a holder of the number of securities deliverable upon exercise of this Warrant immediately before that change would have been entitled to receive in such Reclassification, all subject to further
adjustment as provided herein with respect to such other shares. 
 (c)    Subdivisions and Combinations.
In the event that the outstanding shares of Common Stock are subdivided (by stock split, by payment of a stock dividend or otherwise) into a greater number of shares of such securities, the number of Shares issuable upon exercise of the rights under
this Warrant immediately prior to such subdivision shall, concurrently with the effectiveness of such subdivision, be proportionately increased, and the Exercise Price shall be proportionately decreased, and in the event that the outstanding shares
of Common Stock are combined (by reclassification or otherwise) into a lesser number of shares of such securities, the number of Shares issuable upon exercise of the rights under this Warrant immediately prior to such combination shall, concurrently
with the effectiveness of such combination, be proportionately decreased, and the Exercise Price shall be proportionately increased. 

(d)    Notice of Adjustments. Upon any adjustment in accordance with this Section 6, the Company shall
give notice thereof to the Holder, which notice shall state the event giving rise to the adjustment, the Exercise Price as adjusted and the number of securities or other property purchasable upon the exercise of the rights under this Warrant,
setting forth in reasonable detail the method of calculation of each. The Company shall, upon the written request of any Holder, furnish or cause to be furnished to such Holder a certificate setting forth (i) such adjustments, (ii) the
Exercise Price at the time in effect and (iii) the number of securities and the amount, if any, of other property that at the time would be received upon exercise of this Warrant. 

7.    Notification of Certain Events. Prior to the expiration of this Warrant pursuant to Section 8, in
the event that the Company shall authorize: 
 (a)    the issuance of any dividend or other distribution on the capital
stock of the Company (other than (i) dividends or distributions otherwise provided for in Section 6, (ii) repurchases of common stock issued to or held by employees, officers, directors or consultants of the Company or its
subsidiaries upon termination of their employment or services pursuant to agreements providing for the right of said repurchase; or (iii) repurchases of common stock issued to or held by employees, officers, directors or consultants of the
Company or its subsidiaries pursuant to rights of first refusal or first offer contained in agreements providing for such rights), whether in cash, property, stock or other securities; or 

(b)    the voluntary liquidation, dissolution or winding up of the Company; or 

(c)    any transaction resulting in the expiration of this Warrant pursuant to Section 8(b) or 8(c); 

the Company shall send to the Holder of this Warrant at least ten (10) business days prior written notice of the date on which a record shall be taken
for any such dividend or distribution specified in clause (a) or the expected effective date of any such other event specified in clause (b) or (c), as applicable. The notice provisions set forth in this section may be shortened or waived
prospectively or retrospectively by the consent of the Holder of this Warrant. 
 8.    Expiration of the
Warrant. This Warrant shall expire and shall no longer be exercisable as of the earlier of: 
 (a)    5:00 p.m.,
Pacific Time, on February 4, 2027; or 

  
 6 

 (b)    the acquisition of the Company by another entity by means of any
transaction or series of related transactions to which the Company is a party (including, without limitation, any stock acquisition, reorganization, merger or consolidation, but excluding any sale of stock for capital raising purposes and any
transaction effected primarily for purposes of changing the Company’s jurisdiction of incorporation) other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately
prior to such transaction or series of related transactions retain, immediately after such transaction or series of transactions, as a result of shares in the Company held by such holders prior to such transaction or series of transactions, at least
a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity (or if the Company or such other surviving or resulting entity is a wholly-owned subsidiary immediately
following such acquisition, its parent), or (ii) a sale, lease or other disposition of all or substantially all of the assets of the Company and its subsidiaries taken as a whole by means of any transaction or series of related transactions,
except where such sale, lease or other disposition is to a wholly-owned subsidiary of the Company. 
 9.    No
Rights as a Stockholder. Nothing contained herein shall entitle the Holder to any rights as a stockholder of the Company or to be deemed the holder of any securities that may at any time be issuable on the exercise of the rights hereunder for
any purpose nor shall anything contained herein be construed to confer upon the Holder, as such, any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to
any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value or change of stock to no par value, consolidation, merger, conveyance or otherwise) or to receive notice of meetings, or to
receive dividends or subscription rights or any other rights of a stockholder of the Company until the rights under the Warrant shall have been exercised and the Shares purchasable upon exercise of the rights hereunder shall have become deliverable
as provided herein. 
 10.    Representations and Warranties of the Holder. By acceptance of this Warrant,
the Holder represents and warrants to the Company as follows: 
 (a)    No Registration. The Holder
understands that the Securities have not been, and will not be, registered under the Securities Act by reason of a specific exemption from the registration provisions of the Securities Act, the availability of which depends upon, among other things,
the bona fide nature of the investment intent and the accuracy of the Holder’s representations as expressed herein or otherwise made pursuant hereto. 

(b)    Investment Intent. The Holder is acquiring the Securities for investment for its own account, not as
a nominee or agent, and not with a view to, or for resale in connection with, any distribution thereof. The Holder has no present intention of selling, granting any participation in, or otherwise distributing the Securities, nor does it have any
contract, undertaking, agreement or arrangement for the same. 
 (c)    Investment Experience. The Holder
has substantial experience in evaluating and investing in private placement transactions of securities in companies similar to the Company, and has such knowledge and experience in financial or business matters so that it is capable of evaluating
the merits and risks of its investment in the Company and protecting its own interests. 
 (d)    Speculative
Nature of Investment. The Holder understands and acknowledges that its investment in the Company is highly speculative and involves substantial risks. The Holder can bear the economic risk of its investment and is able, without impairing its
financial condition, to hold the Securities for an indefinite period of time and to suffer a complete loss of its investment. 

(e)    Access to Information. The Holder believes that it has received all the information that it considers
necessary or appropriate for deciding whether to acquire the Securities. 
 (f)    Accredited Investor.
The Holder is an “accredited investor” within the meaning of Regulation D, Rule 501(a), promulgated by the Securities and Exchange Commission and agrees to submit to the Company such further assurances of such status as may be
reasonably requested by the Company. 

  
 7 

 (g)    Residency. The residency of the Holder (or, in the
case of a partnership or corporation, such entity’s principal place of business) is correctly set forth on the signature page hereto. 

(h)    Restrictions on Resales. The Holder acknowledges that the Securities must be held indefinitely unless
subsequently registered under the Securities Act or an exemption from such registration is available. The Holder is aware of the provisions of Rule 144 promulgated under the Securities Act, which permit resale of shares purchased in a private
placement subject to the satisfaction of certain conditions, which may include, among other things, the availability of certain current public information about the Company; the resale occurring not less than a specified period after a party has
purchased and paid for the security to be sold; the number of shares being sold during any three-month period not exceeding specified limitations; the sale being effected through a “broker’s transaction,” a transaction directly with a
“market maker” or a “riskless principal transaction” (as those terms are defined in the Securities Act or the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder); and the filing of a
Form 144 notice, if applicable. The Holder acknowledges and understands that (i) the Company was formerly a shell company and Rule 144 is not available for the resale of securities initially issued by shell companies or issuers that have
been at any time previously a shell company, until, among other requirements, at least one year has elapsed from the time that the issuer filed current Form 10 type information with the Securities and Exchange Commission reflecting its status
as an entity that is not a shell company, which information the Company filed on September 5, 2019, and (ii) the Company may not be satisfying the current public information requirement of Rule 144 at the time the Holder wishes to
sell the Securities and that, in such event, the Holder may be precluded from selling the Securities under Rule 144 even if the other applicable requirements of Rule 144 have been satisfied. The Holder acknowledges that, in the event the
applicable requirements of Rule 144 are not met, registration under the Securities Act or an exemption from registration will be required for any disposition of the Securities. The Holder understands that, although Rule 144 is not
exclusive, the Securities and Exchange Commission has expressed its opinion that persons proposing to sell restricted securities received in a private offering other than in a registered offering or pursuant to Rule 144 will have a substantial
burden of proof in establishing that an exemption from registration is available for such offers or sales and that such persons and the brokers who participate in the transactions do so at their own risk. 

(i)    No Public Market. The Holder understands and acknowledges that the Company has made no assurances
that a public market will continue to exist for the Company’s securities. 
 (j)    Brokers and
Finders. The Holder has not engaged any brokers, finders or agents in connection with the Securities, and the Company has not incurred nor will incur, directly or indirectly, as a result of any action taken by the Holder, any liability for
brokerage or finders’ fees or agents’ commissions or any similar charges in connection with the Securities. 

(k)    Legal Counsel. The Holder has had the opportunity to review this Warrant, the exhibits and schedules
attached hereto and the transactions contemplated by this Warrant with its own legal counsel. The Holder is not relying on any statements or representations of the Company or its agents for legal advice with respect to this investment or the
transactions contemplated by this Warrant. 
 (l)    Tax Advisors. The Holder has reviewed with its own
tax advisors the U.S. federal, state and local and non-U.S. tax consequences of this investment and the transactions contemplated by this Warrant. With respect to such matters, the Holder relies solely on any
such advisors and not on any statements or representations of the Company or any of its agents, written or oral. The Holder understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this
investment and the transactions contemplated by this Warrant. 
 (m)    No “Bad
Actor” Disqualification. Neither (i) the Holder, (ii) any of its directors, executive officers, other officers that may serve as a director or officer of any company in which it
invests, general partners or managing members, nor (iii) any beneficial owner of any of the Company’s voting equity securities (in accordance with Rule 506(d) of the Securities Act) held by the Holder is subject to any of the
“bad actor” disqualifications described in Rule 506(d)(1)(i) through (viii) under the Securities Act, except as set forth in Rule 506(d)(2)(ii) or (iii) or (d)(3) under the Securities Act and disclosed, reasonably in
advance of the acceptance of this Warrant, in writing in reasonable detail to the Company. 

  
 8 

 11.    Registration Rights. If (but without any obligation
to do so) the Company proposes to register (including, for this purpose, a registration effected by the Company for stockholders other than the Holder) any of its common stock under the Securities Act in connection with the public offering of such
securities solely for cash (other than in an Excluded Registration (as defined below)), the Company shall, at such time, promptly give the Holder written notice of such registration. Upon the written request of the Holder given within twenty
(20) days after such notice is given by the Company, the Company shall use commercially reasonable efforts to cause to be registered under the Securities Act all of the Shares then issuable upon exercise of this Warrant that the Holder has
requested to be included in such registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 11 before the effective date of such registration, whether or not the Holder has
elected to include any Shares in such registration. The expenses of registering the Shares pursuant to this Section 11 shall be borne by the Company; provided, that, the Company shall have no obligation to pay for the fees or expenses of
Holder’s counsel in connection with such registration. For purposes of this Section 11, an “Excluded Registration” means (i) a registration relating to the sale or grant of securities to employees of the Company or a
subsidiary pursuant to a stock option, stock purchase, equity incentive or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii) a registration on any form that does not include substantially the same information
as would be required to be included in a registration statement covering the sale of the Shares; (iv) a registration in which the only Company common stock being registered is common stock issuable upon conversion of debt securities that are
also being registered; (v) a registration involving an underwriting of shares of the Company’s capital stock; or (vi) a registration on any form first filed with the SEC before January 4, 2020. 

12.    Miscellaneous. 

(a)    Amendments. Except as expressly provided herein, neither this Warrant nor any term hereof may be
amended, waived, discharged or terminated other than by a written instrument referencing this Warrant and signed by the Company and Holder. 

(b)    Waivers. No waiver of any single breach or default shall be deemed a waiver of any other breach or
default theretofore or thereafter occurring. 
 (c)    Notices. All notices and other communications
required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or otherwise delivered by hand, messenger or courier service addressed: 

(i)    if to the Holder, to the Holder at the Holder’s address, or facsimile number as shown in the Company’s
records, as may be updated in accordance with the provisions hereof, or until any such Holder so furnishes an address, or facsimile number to the Company, then to and at the address, or facsimile number of the last holder of this Warrant for which
the Company has contact information in its records; or 
 (ii)    if to the Company, to the attention of the President
or Chief Financial Officer of the Company at the Company’s address as shown on the signature page hereto, or at such other address as the Company shall have furnished to the Holder. 

Each such notice or other communication shall for all purposes of this Warrant be treated as effective or having been given the earlier of
(i) when received, (ii) when delivered personally, (iii) one business day after being delivered by facsimile (with receipt of appropriate confirmation), (iv) one business day after being deposited with an overnight courier service of
recognized standing or (v) four days after being deposited in the U.S. mail, first class with postage prepaid. 

(d)    Governing Law. This Warrant and all actions arising out of or in connection with this Warrant shall
be governed by and construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California, or of any other state. 

(e)    Jurisdiction and Venue. Each of the Holder and the Company irrevocably consents to the
exclusive jurisdiction and venue of any court within San Diego, California, in connection with any matter based upon or 

  
 9 

 
arising out of this Warrant or the matters contemplated herein, and agrees that process may be served upon them in any manner authorized by the laws of the State of California for such persons.

 (f)    Titles and Subtitles. The titles and subtitles used in this Warrant are used for convenience
only and are not to be considered in construing or interpreting this Warrant. All references in this Warrant to sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto.

 (g)    Severability. If any provision of this Warrant becomes or is declared by a court of competent
jurisdiction to be illegal, unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Warrant, and such illegal, unenforceable or void provision shall be replaced with a
valid and enforceable provision that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, unenforceable or void provision. The balance of this Warrant shall be enforceable in accordance with its terms.

 (h)    Waiver of Jury Trial. EACH OF THE HOLDER AND THE COMPANY WAIVES, TO THE FULLEST
EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS WARRANT. If the waiver of jury trial set forth in this paragraph is not
enforceable, then any claim or cause of action arising out of or relating to this Warrant shall be settled by judicial reference pursuant to California Code of Civil Procedure Section 638 et seq. before a referee sitting without a jury,
such referee to be mutually acceptable to the parties or, if no agreement is reached, by a referee appointed by the Presiding Judge of the California Superior Court for San Diego County. This paragraph shall not restrict the Holder or the Company
from exercising remedies under the Uniform Commercial Code or from exercising pre-judgment remedies under applicable law. 

(i)    California Corporate Securities Law. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS WARRANT
HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE
OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS WARRANT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO
EXEMPT. 
 (j)    Saturdays, Sundays and Holidays. If the last or appointed day for the taking of any
action or the expiration of any right required or granted herein shall be a Saturday, Sunday or U.S. federal holiday, then such action may be taken or such right may be exercised on the next succeeding day that is not a Saturday, Sunday or U.S.
federal holiday. 
 (k)    Rights and Obligations Survive Exercise of the Warrant. Except as otherwise
provided herein, the rights and obligations of the Company and the Holder under this Warrant shall survive exercise of this Warrant. 

(l)    Entire Agreement. Except as expressly set forth herein, this Warrant (including the exhibits attached
hereto) constitutes the entire agreement and understanding of the Company and the Holder with respect to the subject matter hereof and supersede all prior agreements and understandings relating to the subject matter hereof. 

(signature page follows) 

  
 10 

 The Company signs this Warrant as of the date stated on the first page. 

 

			
	DERMTECH, INC.
		
	By:	 	
                    

		
	Name:	 	  

		
	Title:	 	  

 EXHIBIT A 

NOTICE OF EXERCISE 

TO:                    DermTech, Inc. (the
“Company”) 
 Attention:          President 

 

	(1)	 Exercise. The undersigned elects to purchase the following pursuant to the terms of the attached
warrant: 

  

					
		 	Number of shares:	 	  

			
		 	Type of security:	 	  

  

	(2)	 Method of Exercise. The undersigned elects to exercise the attached warrant pursuant to:

  

	 	☐	 A cash payment or cancellation of indebtedness, and tenders herewith payment of the purchase price for such
shares in full, together with all applicable transfer taxes, if any. 

  

	 	☐	 The net issue exercise provisions of Section 2(b) of the attached warrant. 

 

	(3)	 Conditional Exercise. Is this a conditional exercise pursuant to Section 2(e):

  

									
		 	☐	  	Yes	  	☐	  	No                        
	  

            
	 	  

If   “Yes,” indicate the applicable condition:

		
		 	  

  

	(4)	 Payment of the Purchase Price. The undersigned hereby tenders herewith for the exercise price of the
warrant either a cash payment or evidence of the cancellation of indebtedness owed by the Company to the undersigned in an amount equal to the purchase price for such shares in full, together with all applicable transfer taxes, if any.

  

	(5)	 Book Entry Position. Please record the undersigned’s book entry position with the Company’s
transfer agent, representing the shares in the name of: 

  

							
		 	☐	 	The undersigned	 	                                      
                                         
                                 
				
		 	☐	 	Other—Name:    	 	
                     
                   

				
	            	 	    	 	Address: 	 	 
				
		 	    	 	Address: 	 	 
		
	                	 	Social Security or Federal Tax I.D.
Number:                                        
                                         
                                         
                           

  

	(6)	 Unexercised Portion of the Warrant. Please issue a new warrant for the unexercised portion of the
attached warrant in the name of: 

  

							
		 	☐	 	The undersigned	  	
				
		 	☐	 	Other—Name:    	  	  

				
		 		 	Address: 	  	 
				
		 	☐	 	Not applicable    	  	

	(7)	 Investment Intent. The undersigned represents and warrants that the aforesaid shares are being acquired
for investment for its own account, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and that the undersigned has no present intention of selling, granting any participation in, or
otherwise distributing the shares, nor does it have any contract, undertaking, agreement or arrangement for the same, and all representations and warranties of the undersigned set forth in Section 10 of the attached warrant are true and correct
as of the date hereof. 

  

	(8)	 Investment Representation Statement. The undersigned has executed, and delivers herewith, an Investment
Representation Statement Agreement in a form substantially similar to the form attached to the warrant as Exhibit A-1. 

 

	
	  
 (Print name
of the warrant holder)

	
	  

(Signature)

	
	  
 (Name and
title of signatory, if applicable)

	
	  

(Date)

	
	  
 (Fax
number)

 EXHIBIT A-l 

INVESTMENT REPRESENTATION STATEMENT 
  

			
	INVESTOR:	  	  

		
	COMPANY:	  	DERMTECH, INC.
		
	SECURITIES:	  	THE WARRANT DATED FEBRUARY 4, 2020 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF
		
	DATE:	  	  

 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor
represents and warrants to, and agrees with, the Company as follows: 
 1.    No Registration. The Investor
understands that the Securities have not been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”), by reason of a specific exemption from the registration provisions of the
Securities Act, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Investor’s representations as expressed herein or otherwise made pursuant hereto. 

2. Investment Intent. The Investor is acquiring the Securities for investment for its own account, not as a nominee or agent, and not
with a view to, or for resale in connection with, any distribution thereof. The Investor has no present intention of selling, granting any participation in, or otherwise distributing the Securities, nor does it have any contract, undertaking,
agreement or arrangement for the same. 
 3.    Investment Experience. The Investor has substantial experience in
evaluating and investing in private placement transactions of securities in companies similar to the Company, and has such knowledge and experience in financial or business matters so that it is capable of evaluating the merits and risks of its
investment in the Company and protecting its own interests. 
 4.    Speculative Nature of Investment. The
Investor understands and acknowledges that its investment in the Company is highly speculative and involves substantial risks. The Investor can bear the economic risk of its investment and is able, without impairing its financial condition, to hold
the Securities for an indefinite period of time and to suffer a complete loss of its investment. 
 5.    Access to
Information. The Investor believes that it has received all the information that it considers necessary or appropriate for deciding whether to acquire the Securities. 

6.    Accredited Investor. The Investor is an “accredited investor” within the meaning of
Regulation D, Rule 501(a), promulgated by the Securities and Exchange Commission and agrees to submit to the Company such further assurances of such status as may be reasonably requested by the Company. 

7.    Residency. The residency of the Investor (or, in the case of a partnership or corporation, such entity’s
principal place of business) is correctly set forth on the signature page hereto. 
 8.    Restrictions on
Resales. The Investor acknowledges that the Securities must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available. The Investor is aware of the provisions of
Rule 144 promulgated under the Securities Act, which permit resale of shares purchased in a private placement subject to the satisfaction of certain conditions, which may include, among other things, the availability of certain current public
information about the Company; the resale occurring not less than a specified period after a party has purchased and paid for the security to be sold; the number of shares being sold during any three-month period not exceeding specified limitations;
the sale being effected through a “broker’s transaction,” a transaction directly with a “market maker” or a “riskless principal transaction” (as those terms are defined in the Securities Act or the

 
Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder); and the filing of a Form 144 notice, if applicable. The Investor acknowledges and understands
that (i) the Company was formerly a shell company and Rule 144 is not available for the resale of securities initially issued by shell companies or issuers that have been at any time previously a shell company, until, among other
requirements, at least one year has elapsed from the time that the issuer filed current Form 10 type information with the Securities and Exchange Commission reflecting its status as an entity that is not a shell company, which information the
Company filed on September 5, 2019, and (ii) the Company may not be satisfying the current public information requirement of Rule 144 at the time the Investor wishes to sell the Securities and that, in such event, the Investor may be
precluded from selling the Securities under Rule 144 even if the other applicable requirements of Rule 144 have been satisfied. The Investor understands and acknowledges that, in the event the applicable requirements of Rule 144 are
not met, registration under the Securities Act or an exemption from registration will be required for any disposition of the Securities. The Investor understands that, although Rule 144 is not exclusive, the Securities and Exchange Commission
has expressed its opinion that persons proposing to sell restricted securities received in a private offering other than in a registered offering or pursuant to Rule 144 will have a substantial burden of proof in establishing that an exemption
from registration is available for those offers or sales and that those persons and the brokers who participate in the transactions do so at their own risk. 

9.    No Public Market. The Holder understands and acknowledges that the Company has made no assurances that a
public market will continue to exist for the Company’s securities. 
 10.    Brokers and Finders. The
Investor has not engaged any brokers, finders or agents in connection with the Securities, and the Company has not incurred nor will incur, directly or indirectly, as a result of any action taken by the Investor, any liability for brokerage or
finders’ fees or agents’ commissions or any similar charges in connection with the Securities. 

11.    Legal Counsel. The Investor has had the opportunity to review the Warrant, the exhibits and schedules
attached thereto and the transactions contemplated by the Warrant with its own legal counsel. The Investor is not relying on any statements or representations of the Company or its agents for legal advice with respect to this investment or the
transactions contemplated by the Warrant. 
 12.    Tax Advisors. The Investor has reviewed with its own tax
advisors the U.S. federal, state and local and non-U.S. tax consequences of this investment and the transactions contemplated by the Warrant. With respect to such matters, the Investor relies solely on such
advisors and not on any statements or representations of the Company or any of its agents, written or oral. The Investor understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this
investment or the transactions contemplated by the Warrant. 
 (signature page follows) 

 The Investor is signing this Investment Representation Statement Agreement on the date first
written above. 
  

	
	INVESTOR
	  
 (Print name
of the investor)

	
	  

(Signature)

	
	  
 (Name and
title of signatory, if applicable)

	
	  
 (Street
address)

	
	  
 (City,
state and ZIP)

 EXHIBIT B 

ASSIGNMENT FORM 
  

			
	ASSIGNOR:	  	  

		
	COMPANY:	  	DERMTECH, INC.
		
	WARRANT:	  	THE WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED ON FEBRUARY 4, 2020 (THE “WARRANT”)
		
	DATE:	  	                        

 (1)    Assignment. The undersigned registered holder of the Warrant
(“Assignor”) assigns and transfers to the assignee named below (“Assignee”) all of the rights of Assignor under the Warrant, with respect to the number of shares set forth below: 

 

					
		
		 	Name of Assignee:                               
                                         
                                         
                                         
                                      
		
		 	Address of Assignee:                              
                                         
                                         
                                         
                                    
		
		 	
                      
                                         
                                         
                                         
                                       

		
		 	Social Security or Federal Tax I.D. Number:                       
                                         
                                         
                                         
      
		
		 	Number of Shares Assigned:                             
                                         
                                         
                                         
                         

 and does irrevocably constitute and appoint
                     as attorney to make such transfer on the books of DermTech, Inc., maintained for the purpose, with full power of
substitution in the premises. 
  

	(2)	 Obligations of Assignee. Assignee agrees to take and hold the Warrant and any shares of stock to be
issued upon exercise of the rights thereunder (the “Securities”) subject to, and to be bound by, the terms and conditions set forth in the Warrant, to the same extent as if Assignee were the original holder thereof.

  

	(3)	 Investment Intent. Assignee represents and warrants that the Securities are being acquired for
investment for its own account, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and that Assignee has no present intention of selling, granting any participation in, or otherwise
distributing the shares, nor does it have any contract, undertaking, agreement or arrangement for the same, and all representations and warranties set forth in Section 10 of the Warrant are true and correct as to Assignee as of the date hereof.

  

	(4)	 Investment Representation Statement. Assignee has executed, and delivers herewith, an Investment
Representation Statement in a form substantially similar to the form attached to the Warrant as Exhibit A-1. 

  
 1 

 Assignor and Assignee are signing this Assignment Form on the date first set forth above.

  

					
	 ASSIGNOR
  

(Print name of Assignor)
  

(Signature of Assignor)
  

(Print name of signatory, if applicable)

 
 (Print title of signatory, if
applicable)
  
 Address:

 
	 		 	 ASSIGNEE
  

(Print name of Assignee)
  

(Signature of Assignee)
  

(Print name of signatory, if applicable)

 
 (Print title of signatory, if
applicable)
  
 Address:

 

	  
	 		 	  

	  
	 		 	  

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00303-of-00352.parquet"}]]